Cerebrospinal fluid (CSF) analysis is routinely used in the diagnostic work-up of multiple sclerosis (MS), by detecting CSF-specific oligoclonal bands (OCB). More recently, several studies have reported CSF free light chains (FLC) as an alternative. We show that absolute CSF κFLC concentrations were highly sensitive -more than OCB testing -and specific for clinically isolated syndrome, relapsing remitting and primary progressive MS. Measurement of κFLC alone was sufficient. Our results suggest that CSF κFLC levels measured by nephelometry, if validated in a larger series, are a preferred test to OCB analysis in the diagnostic work-up of patients suspected of having MS.
Introduction
The pathogenesis of multiple sclerosis (MS) involves inflammatory demyelination, thought to involve the activation of autoreactive T cells that in turn activate microglia and recruit macrophages, which cause demyelination and subsequent neurological damage (Disanto et al., 2010; Nylander and Hafler, 2012) . In addition, meningeal ectopic B cell follicles and plasmablasts in the CSF have been reported; these cells are also likely to contribute to the pathology of MS (Aloisi et al., 2010; Meinl et al., 2006) . Despite refinements in MRI imaging protocols for the diagnosis of MS, the detection of intrathecal immunoglobulin, produced by these central nervous system resident B cells, continues to be an important component of the diagnostic pathway for MS (Katsavos and Anagnostouli, 2013; Tumani et al., 2009 ). In addition to diagnostic information, particularly when MRI imaging is inconclusive, the presence of CSF specific OCB may provide prognostic information, for example in the prediction of conversion from clinically isolated syndrome (CIS), the first presenting neurological event, to relapsing remitting disease (RR-MS) (Villar et al., 2012) .
Traditionally, the assay for the presence of CSF immunoglobulin is performed using gel isoelectrofocusing and immunoblotting, allowing the visualisation of oligoclonal bands which may or may not be mirrored in the matched serum sample (Katsavos and Anagnostouli, 2013; Tumani et al., 2009 ). There are many difficulties with this test including requirements for a matched serum sample, manual handling, limited sensitivity and the potential for subjective interpretation. In an attempt to address these issues, a number of recent studies have employed the detection of CSF free light chains (FLC) as a measure of intrathecal immunoglobulin synthesis (Arneth and Birklein, 2009; Duranti et al., 2013; Kaplan et al., 2013; Presslauer et al., 2008; Senel et al., 2014; Villar et al., 2012) . Light chains are produced in excess during antibody formation and are secreted from the plasma cells/ plasmablasts, with a serum half-life of 2-6 hours primarily through renal clearance (Solling, 1981) . This pathway is absent for the CSF and FLC levels may therefore remain elevated for prolonged periods, to the point where even very small amounts of intrathecal FLC synthesis become detectable. The majority of studies on FLC in the CSF have shown an increased sensitivity and specificity for MS diagnosis as compared to traditional OCB detection (Arneth and Birklein, 2009; Duranti et al., 2013; Kaplan et al., 2013; Presslauer et al., 2008; Villar et al., 2012) . However, the specific results vary according to the assay methodology, using either ELISA or nephelometry (Senel et al., 2014) which may have different sensitivities, and with the use of an index measure of FLC (Duranti et al., 2013; Messaoudani et al., 2014; Presslauer et al., 2008) , for example (CSF FLC/serum FLC)/(CSF albumin/serum albumin).
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